EU pharmaceutical expenditure forecast

Pharmaceutical expenditure forecast model to support health policy decision making

BACKGROUND AND OBJECTIVE With constant incentives for healthcare payers to contain their pharmaceutical budgets, modelling policy decision impact became critical. The objective of this project was to test the impact of various policy decisions on pharmaceutical budget (developed for the European Commission for the project 'European Union (EU) Pharmaceutical expenditure forecast' - http://ec.eur...

Public pharmaceutical expenditure: identification of spatial effects

Forecasting Outpatient Pharmaceutical Expenditure for Cancer Treatment in Germany.

If a new drug is supposed to replace existing pharmaceuticals we subtracted costs of replaced drugs [table 2]. If a new drug is supposed to be given additionally, we added costs of new drugs. For calculations, we assumed that newly launched drugs will reach on average a diffusion of 20% of their market potential until 2016. Market potential was defined as for a new drug eligible patients. To as...

Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia

In the lowand middle-income countries some non-communicable diseases (NCDs), such are cardiac diseases, strokes, chronic lung diseases, certain cancers, and diabetes, tend to overtake the morbidity and mortality of poverty diseases (Adams and Butterly, 2015; Jakovljevic and Getzen, 2016). Such diseases, conditionally labeled as diseases of affluence (Nutrition Health Topics, 2016), are growing ...

Cost Containment Measures for Pharmaceuticals Expenditure in the EU Countries: A Comparative Analysis

A vast majority of the EU countries are witnessing a rise in the share of public pharmaceutical spending in the total drugs expenditure. This urges governments to adopt cost containment measures through more stringent norms in their pharmaceutical policies. The aim of this paper is to review the existing pharmaceuticals cost-containment policies in the EU in order to illustrate the complexity o...